Depomed Confirms Receipt of Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc
Consistent with its fiduciary duties,
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties including, but not limited to, those related to
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/depomed-confirms-receipt-of-purported-revised-highly-conditional-unsolicited-proposal-from-horizon-pharma-plc-300116351.html
Investor Contact: Depomed, Inc., August J. Moretti, 510-744-8000, firstname.lastname@example.org or Christopher Keenan, 510-744-8526, email@example.com; Innisfree M&A Incorporated, Larry Miller / Jonathan Salzberger / Scott Winter, (212) 750-5833; Media Contact: Joele Frank, Wilkinson Brimmer Katcher, Eric Brielmann, 415-869-3950, Andy Brimmer and Averell Withers, 212-355-4449
Minimum 15 minutes delayed.